Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pain Therapeutics (PTIE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 35,989
  • Shares Outstanding, K 46,140
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,850 K
  • 36-Month Beta 2.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.96
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/04/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.75 on 12/13/12
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.75 +4.00%
on 04/06/17
1.08 -27.78%
on 03/23/17
-0.21 (-21.21%)
since 03/21/17
3-Month
0.53 +47.17%
on 01/30/17
1.33 -41.35%
on 03/21/17
+0.20 (+34.48%)
since 01/20/17
52-Week
0.51 +52.94%
on 11/04/16
3.00 -74.00%
on 09/20/16
-1.55 (-66.52%)
since 04/21/16

Most Recent Stories

More News
Pain Therapeutics Report (2017-2026) - Assessment of Pain & Analgesics - Research and Markets

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering.

PTIE : 0.78 (-1.27%)
Global 2017 Pain Therapeutics Drugs, Markets and Companies Report 2017 - Projections to 2026

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering.

PTIE : 0.78 (-1.27%)
Pain Therapeutics Report (2017-2026) - Profiles of 173 Companies & 153 Collaborations - Research and Markets

DUBLIN, April 06, 2017 /PRNewswire/ --

PTIE : 0.78 (-1.27%)
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER

Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced positive regulatory guidance from a recent meeting with the U.S. Food and Drug Administration (FDA) regarding REMOXY (extended-release oxycodone capsules...

PTIE : 0.78 (-1.27%)
Pain Therapeutics Attendee List Released Featuring Scientific Leaders and Top Industry Experts

Aimed at capturing the latest clinical developments in pain management, SMi Group's timely Pain Therapeutics summit will gather an audience of scientific pioneers and industry experts when it takes place...

PTIE : 0.78 (-1.27%)
Pain Therapeutics to Discuss REMOXY(R) ER with FDA

Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced it plans to meet with the U.S. Food and Drug Administration (FDA) in person on Monday, February 13, 2017 to discuss the regulatory path forward for...

PTIE : 0.78 (-1.27%)
Global Pain Therapeutics Drugs, Markets and Companies report 2015-2025: Epidemiology of Various Painful Conditions and the Development of Analgesic Drugs and Devices

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering.

PTIE : 0.78 (-1.27%)
Research Reports Initiation on Biotech Stocks -- Pacific Biosciences of California, Aralez Pharma, Cerus, and Pain Therapeutics

Stock-Callers.com has issued research reports on four Biotech equities, which are Pacific Biosciences of California Inc. (NASDAQ: PACB), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ), Cerus Corp. (NASDAQ:...

ARLZ : 1.57 (-4.27%)
PACB : 5.05 (+6.99%)
PTIE : 0.78 (-1.27%)
CERS : 4.12 (-2.60%)
Research Reports Initiation on Biotech Stocks -- Spectrum Pharma, Pain Therapeutics, CoLucid Pharma, and CEL-SCI

Stock-Callers.com has initiated coverage on the following Biotechnology companies: Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), Pain Therapeutics Inc. (NASDAQ: PTIE), CoLucid Pharmaceuticals Inc. (NASDAQ:...

SPPI : 7.09 (+1.72%)
PTIE : 0.78 (-1.27%)
CLCD : 46.53 (+0.06%)
CVM : 0.09 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical...

See More

Support & Resistance

2nd Resistance Point 0.81
1st Resistance Point 0.80
Last Price 0.78
1st Support Level 0.77
2nd Support Level 0.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.